Southeast Retina Center, Georgia

Quick facts

Marketed products

• Alflibercept · Other
• Rescue Intravitreal Aflibercept Injection · Ophthalmology
  Aflibercept is a recombinant fusion protein that binds vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) to inhibit abnormal blood vessel growth in the retina.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Southeast Retina Center, Georgia portfolio CI brief
• Southeast Retina Center, Georgia pipeline updates RSS